Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Lactose (India) Ltd.
Source DateBoard Meeting DateDetails
07-Nov-2025 13-Nov-2025 Quarterly Results
07-Aug-2025 13-Aug-2025 Quarterly Results
21-May-2025 30-May-2025 Quarterly Results
06-Feb-2025 12-Feb-2025 Quarterly Results
02-Dec-2024 05-Dec-2024 Inter alia, to consider and approve : 1. Allotment of 15,00,000 Convertible Warrants on preferential basis. 2. Any other business with the permission of chair.
21-Oct-2024 23-Oct-2024 Inter alia, to consider and approve:- 1. To consider issue upto 15,00,000 (Fifteen Lakhs) convertible warrants on preferential basis, in accordance with Section 42 and 62(1)(c) of the Companies Act, 2013 and all other applicable provisions, if any, (including any statutory modification(s) or re-enactments thereof for the time being in force), Memorandum and Articles of Association of the Company, SEBI (LODR), and in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and to fix the date, time and venue of the Extra Ordinary General Meeting of the members of the company for their approval of the funds proposed to be raised; 2. To approve the scheme of merger between Lactose (India) Limited and Vitanosh Ingredients Private Limited; 3. To consider any other business with the permission of chair.
16-Oct-2024 21-Oct-2024 Inter alia, to consider and approve:- 1. To appoint M/s. DMKH & Co, Chartered Accountants, as statutory auditors in casual vacancy; 2. To consider any other business with the permission of chair.
10-Oct-2024 15-Oct-2024 Quarterly Results & Inter alia, to consider and approve:- 1.To take on record resignation of Statutory Auditor M/s. S G C O & Co. LLP w.e.f. 09th October, 2024. 2.To consider any other business with the permission of chair
06-Aug-2024 12-Aug-2024 Quarterly Results
23-May-2024 30-May-2024 Audited Results
05-Feb-2024 14-Feb-2024 Quarterly Results
23-Oct-2023 02-Nov-2023 Quarterly Results
04-Aug-2023 14-Aug-2023 Quarterly Results
24-Jul-2023 27-Jul-2023 Inter alia, to consider and approve:- 1. To approve the Director?s Report for the Financial Year Ended 31st March, 2023. 2. To approve of draft notice of Annual General Meeting of the Company and fix to fix the time, place, date of the meeting. 3. To approve re-appointment of Director who?s retiring by rotation. 4. Appointment of Cost Auditor. 5. To consider and approve the Internal Audit Report for the FY 2022-23. 6. To consider and approve the Secretarial Audit Report for the FY 2022-23. 7. To appoint M/s. Jajodia & Associates, Practising Company Secretary as a Scrutinizer for the upcoming AGM. 8. To approve Related Party Transactions for the FY 2023-24 to FY 2025-26. 9. To appoint Internal Auditors for the FY 2023-24. 10. To appoint Secretarial Auditors for the FY 2023-24. 11. To consider any other business with the permission of chair.
23-May-2023 30-May-2023 Audited Results
07-Feb-2023 14-Feb-2023 Quarterly Results
04-Nov-2022 14-Nov-2022 Quarterly Results
01-Aug-2022 09-Aug-2022 Quarterly Results
09-May-2022 17-May-2022 Audited Results & Inter alia, to consider and approve : 1. Audited Financial Results of the Company for the fourth quarter and Financial year ended 31st March, 2022. 2. Audited Financial Statements of the Company for the Financial year ended 31st March, 2022. 3. Director's Report along with annexure for the year ended 31st March, 2022; 4. Draft Notice Convening 31st Annual General Meeting of the company; 5. Any other business with the permission of chair.
23-Mar-2022 28-Mar-2022 Preferential Issue of shares
Page 1 of 7
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.